52 results
SC TO-T/A
EX-99
PNT
POINT Biopharma Global Inc.
18 Dec 23
Third party tender offer statement (amended)
6:59am
, transaction costs, risks that the proposed acquisition disrupts current plans and operations or adversely affects employee retention, potentially diverting
SC TO-T/A
EX-99
PNT
POINT Biopharma Global Inc.
4 Dec 23
Third party tender offer statement (amended)
7:04am
costs, risks that the proposed acquisition disrupts current plans and operations or adversely affects employee retention, potentially diverting
SC TO-T/A
EX-99
PNT
POINT Biopharma Global Inc.
17 Nov 23
Third party tender offer statement (amended)
6:53am
costs, risks that the proposed acquisition disrupts current plans and operations or adversely affects employee retention, potentially diverting
SC TO-T/A
EX-99
LLY
Lilly(Eli) & Co
15 Nov 23
Third party tender offer statement (amended)
6:51am
, transaction costs, risks that the proposed acquisition disrupts current plans and operations or adversely affects employee retention, potentially
SC TO-T/A
EX-99
qwbn2n5eh 82xnzuc36e
8 Nov 23
Third party tender offer statement (amended)
5:06pm
SC 14D9
91jlp6 83gr
13 Oct 23
Tender offer solicitation
7:11am
SC TO-T
EX-99
nifksyc
13 Oct 23
Third party tender offer statement
6:52am
SC TO-T
EX-99
mjk ovbtpzfys1
13 Oct 23
Third party tender offer statement
6:52am
SC TO-C
EX-99.1
gmmalg45f2nsq8dnbv
3 Oct 23
Information about tender offer
4:30pm
SC TO-C
vhwrskn 2bwfc
3 Oct 23
Information about tender offer
4:30pm
SC14D9C
EX-2.1
9gygiulexmmcp
3 Oct 23
Written communication relating to third party tender offer
7:37am
SC14D9C
EX-99.4
oboofmewk j36b
3 Oct 23
Written communication relating to third party tender offer
7:37am
8-K
EX-2.1
d7m42yjy m8c041
3 Oct 23
Tender and Support Agreement
7:35am
8-K
EX-99.4
bkeg538e u3k0
3 Oct 23
Tender and Support Agreement
7:35am
ARS
29gmrzwyii4u2q
1 May 23
Annual report to shareholders
1:52pm